These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3896483)

  • 21. Characterization and chemotherapy of human soft tissue sarcoma (STS) lines grown in nude mice.
    Boven E; Calame JJ; Molthoff CF; Pinedo HM
    Strahlenther Onkol; 1989 Jul; 165(7):538-9. PubMed ID: 2546270
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.
    Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006300. PubMed ID: 23235629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.
    Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006300. PubMed ID: 20166081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of ifosfamide in one-agent chemotherapy of malignant testicular tumors].
    Madej G; Porwit-Ksiazek A; Siedlecki P; Zborzil J
    Pol Tyg Lek; 1982 Jul; 37(24-25):717-9. PubMed ID: 6294642
    [No Abstract]   [Full Text] [Related]  

  • 25. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial.
    Gandola L; Pozzi E; Tansini G
    G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preliminary evaluation of the effectiveness of holoxan in the treatment of malignant soft tissue and bone neoplasms].
    Utracka-Hutka B; Czownicki Z
    Nowotwory; 1981; 31(2):147-53. PubMed ID: 7038629
    [No Abstract]   [Full Text] [Related]  

  • 27. Ifosfamide treatment of advanced ovarian cancer.
    Yazigi R; Wild R; Madrid J; Arraztoa J
    Obstet Gynecol; 1984 Feb; 63(2):163-6. PubMed ID: 6694809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
    Hartwich G; Neidhardt B; Lutz H
    Med Klin; 1978 Sep; 73(36):1247-52. PubMed ID: 692477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy.
    Clemm C; Hartenstein R; Wilmanns W
    Arzneimittelforschung; 1982; 32(12):1557-60. PubMed ID: 6891596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ifosfamide and Mesna in advanced malignancies.
    Li GC; Brock N; Li JQ; Guan ZZ; He YJ
    Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on cytostatic effect of oxazophosphorine metabolites. Role of phospho- and phosphoramide mustards; practical implications].
    Hładoń B
    Acta Pol Pharm; 1982; 39(1-3):185-8. PubMed ID: 7180550
    [No Abstract]   [Full Text] [Related]  

  • 33. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical toxicology of ifosfamide.
    Barnett D
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):8-13. PubMed ID: 6761867
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
    Teufel G; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verwey J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
    Eur J Cancer Clin Oncol; 1987 Mar; 23(3):311-21. PubMed ID: 3595691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adriamycin. A new anticancer drug with significant clinical activity.
    Blum RH; Carter SK
    Ann Intern Med; 1974 Feb; 80(2):249-59. PubMed ID: 4590654
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclophosphamide versus ifosfamide: preliminary report of a randomized phase II trial in adult soft tissue sarcomas.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Thomas D; Sylvester R; Van Oosterom A
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S13-6. PubMed ID: 3102089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparative pharmacology of cyclophosphamide and ifosfamide.
    Colvin M
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):2-7. PubMed ID: 6761865
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary chemosensitivity and secondary drug resistance of xenografted soft part sarcomas.
    Budach V; Budach W; Scheulen M; Czeglarski G
    Strahlenther Onkol; 1989 Jul; 165(7):535-6. PubMed ID: 2473534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.